Article

Respiratory Syncytial Virus disease morbidity in Australian infants aged 0 to 6 months: A systematic review and evaluation

2023-10-27

Abstract excerpt

<h4>Background: </h4> To appraise and synthesise the evidence of respiratory syncytial virus infection morbidity among Australian aged 0 to 6 months, and to assess the implications for future vaccination strategies. Methods Electronic databases (MEDLINE, EMBASE, Pubmed and Global Health) were searched in April 2023. Full-text articles published between 2000 and 2023 in English language that examined markers of di...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a1900df9-c97e-591c-988c-942d6083e5f3
DOI: 10.21203/rs.3.rs-3422393/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Respiratory Syncytial Virus disease morbidity in Australian infants aged 0 to 6 months: A systematic review and evaluationDOI 10.21203/rs.3.rs-3422393/v1Read

The burden of RSV-associated illness in children aged <5 years, South Africa, 2011 to 2016Semantic proximity Read

Factors associated with severe respiratory syncytial virus infection among hospitalized children in Thammasat University HospitalSemantic proximity Read

Cost-effectiveness of respiratory syncytial virus vaccination for older adults: a modelling analysisSemantic proximity Read

Hospitalisation, morbidity and outcomes associated with respiratory syncytial virus compared to influenza in adults of all agesSemantic proximity Read

Burden of Disease of Respiratory Syncytial Virus in Older Adults and Adults Considered at High Risk of Severe InfectionSemantic proximity Read

Respiratory syncytial virus hospitalisations among young children: a data linkage studySemantic proximity Read

COVID-19 in children in NSW, Australia, during the 2021 Delta outbreak: Severity and Disease spectrumSemantic proximity Read

The Epidemiology of Respiratory Syncytial Virus in Children Under Five Years-Old During the COVID-19 Pandemic Measured by Laboratory, Clinical and Syndromic Surveillance in England: A Retrospective Observational Study Including the 2020/21 Winter SeasonSemantic proximity Read

The Impact of Pneumococcal Vaccination on Bacterial and Viral Pneumonia in Western Australian Children: Record Linkage Cohort Study of 469589 Births, 1996–2012Semantic proximity Read

Clinical and economic burden of Respiratory Syncytial Virus in children aged 0-5 years in ItalySemantic proximity Read

Surveillance-based estimation of the impact of introducing a pathfinder programme for nirsevimab immunisation in Ireland on infant hospitalisations due to respiratory syncytial virus in 2024/2025Semantic proximity Read

Off-season RSV epidemics in Australia after easing of COVID-19 restrictionsSemantic proximity Read